Finpecia
Formulated to alleviate prostate enlargement to support urinary stream flow and target hormonal conversion pathways.
- Category
- Prostate Health
- Active ingredient
- Finasteride
- Route
- Oral use
- Form
- Tablet
- Strengths
- 1mg · 5mg
Prescription and consultation requirements for Finpecia vary by destination and are determined by the fulfilment partner.
Finpecia details
- Condition
- Benign Prostatic Hyperplasia
- Alternative names
- finasteride
- Therapeutic class
- 5-Alpha Reductase Inhibitor
- Pharmacological class
- Androgen Synthesis Inhibitor
- Known off-label uses
- androgenetic alopecia
- Contraindications
- pregnancy; hypersensitivity to finasteride
- Minor side effects
- decreased libido; erectile dysfunction
- Moderate side effects
- ejaculation disorder; breast tenderness; depression
- Serious side effects
- allergic angioedema, requires immediate medical attention
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla Ltd
- Onset Time
- 3–6 months
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Age restrictions
- Approved for adult males.
Patient summary
formulated to alleviate prostate enlargement to support urinary stream flow and target hormonal conversion pathways.
Mechanism of action
Inhibits type II 5-alpha reductase, blocking the conversion of testosterone to dihydrotestosterone to reduce prostate tissue volume.
Pregnancy and breastfeeding
TGA Category X: Highly teratogenic to male fetuses. Pregnant women must not handle crushed tablets. Breastfeeding: Not applicable.